This page lists all pharmaceutical reports related to the field of Cardiovascular Disorders. The reports include market research reports and pipeline analyses.
Displaying 51 - 100 of 181 results
- ANEMIA - Therapy Area Pipeline Report
- HEMOPHILIA OR BLOOD COAGULATION DISORDERS - Therapy Area Pipeline Report
- THROMBOEMBOLISM - Therapy Area Pipeline Report
- Critical Limb Ischemia-US Epidemiology
- ANGINA - Therapy Area Pipeline Report
- ARRHYTHMIAS - Therapy Area Pipeline Report
- ATHEROSCLEROSIS and CORONARY ARTERY DISEASE - Therapy Area Pipeline Report
- CONGESTIVE HEART FAILURE - Therapy Area Pipeline Report
- EDEMA - Therapy Area Pipeline Report
- HYPERTENSION - Therapy Area Pipeline Report
- INTERMITTENT CLAUDICATION - Therapy Area Pipeline Report
- ISCHEMIA - Therapy Area Pipeline Report
- MYOCARDIAL INFARCTION - Therapy Area Pipeline Report
- PERIPHERAL VASCULAR DISEASE - Therapy Area Pipeline Report
- STROKE - Therapy Area Pipeline Report
- THROMBOSIS - Therapy Area Pipeline Report
- THROMBOEMBOLISM - Therapy Area Pipeline Report
- THROMBOSIS - Therapy Area Pipeline Report
- Innovations in Cardiovascular Disease Management: Latest surgical procedures, drugs and medical devices
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Anti-Obesity Treatments 2007-2012 - A blockbuster market
- The World Cardiovascular Drug Market: Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents
- Commercial Insight: Cardiovascular market overview - Raft of patent expires threaten blockbusters
- Commercial Insight: Antithrombotics - Market expands as disease management focuses on prevention
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Stakeholder Insight: Acute Stroke - TPA spurs infrastructure changes for the better
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- The World Hypertension Market 2007-2023
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Ventricular Fibrillation and Atrial Fibrillation
- Diabetic Nephropathy - Prevalence and Therapeutic Potential
- 2003 Cardiovascular Market Update
- Thrombosis in Cancer - Expanding Focus for Anticoagulants
- Stakeholder Insight: Atrial Fibrillation - Future Advances in Stroke Prevention
- Commercial Insight: Antithrombotics - Sanofi-Aventis the Dominant Player
- Pipeline Insight: Antihypertensives - Together We Stand, Divided We Fail
- Stakeholder Insight: Metabolic Syndrome - Multiple definitions complicate treatment
- The Outlook for Cardiovascular Risk Factors: Epidemiology, market and pipeline analysis
- The Cardiovascular Market Outlook to 2008
- Commercial Opportunities from an Aging Population: Epidemiology, market and pipeline analysis across seven major indications
- New Anticoagulant Therapies: A Market Briefing
- Cardiovascular Disease: The 45+ Market in the United States for Drugs and Medical Devices
- Gene Expression Profiling Markets
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Pipeline perspectives: Peripheral artery disease Poor disease awareness hinders new agents
- How to Conduct Clinical Trials in China
- The Anti-Migraine Market 2007-2022
- Congestive Heart Failure: Major World Markets - Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)
- Stakeholder Insight: Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture